Lymphoedema Evidence Library
Lymphoedema Evidence Library › Topics › Compression

Compression

Compression: bandaging, garments, wraps and pneumatic devices

55 sources
All 55 sourcesReferences (RIS)Spreadsheet (CSV)

Evidence in one minute

Industry note: almost every compression guidance document held is manufacturer-sponsored (Sigvaris, BSN, Lohmann & Rauscher, medi, Essity, Activa, Haddenham, Juzo).

Update 2026-10-08 — downloaded evidence

  • Prevention (revised 2026-10-08): a sleeve for 4–9% subclinical swelling was not shown to prevent BCRL (PLACE, inconclusive, low certainty); CALGB 70305 did not test prophylactic compression (activity-only sleeve). BIS-triggered sleeves led to less tape-defined chronic BCRL than tape-triggered sleeves (PREVENT, low certainty). Ridner 2022 Paskett 2021 · Bundred 2023 · Ridner 2019
  • IPC: meta-analysis of 14 RCTs (many Chinese) — RR 0.36 for developing BCRL with early low-pressure IPC; little effect in established lymphoedema. Very low certainty (revised 2026-10-08: 5 small prevention trials, contradictory search dates, a subgroup estimate outside its own CI). Su 2025

Appraisal update 2026-10-09

  • Manufacturer-linked material (BSN/JOBST leaflet, Wounds UK quick guides, Charles 2013 SSI article) is accurate on principles but brand-led; cite the ILF/ISL documents for recommendations. The LIPLEG critique arguing that compression was “underrepresented” was translated with compression-industry funding. Wounds UK / BSN medical unknown · Charles 2013 · Bertsch 2025

Update 2026-10-09 — open-access batch 1 (2020–2026 trials and reviews)

  • Adjustable wraps v multilayer bandaging (Reisshauer 2025 RCT): self-applied wraps non-inferior for lower-leg volume over 10 days of intensive CDT (difference 9 mL, margin 50 mL), 8 minutes quicker and more comfortable — low certainty; funded by the wrap maker. Reisshauer 2025
  • IPC for leg lymphoedema (O'Donnell 2026 guideline review): seven small RCTs; the review says moderate certainty, but by its own table only one sequentially allocated trial showed a volume difference v no IPC — low. O'Donnell TF Jr 2026
  • Improvised compression in Africa (Chang 2022, Kenya): locally made zinc-paste bandages (~US$2 per leg per week) added to chemotherapy did not improve Kaposi sarcoma leg lymphoedema in a 30-patient pilot — very low. Chang 2022

Update 2026-10-09 — open-access batch 2

  • Night-time compression: a night sleeve added to day garments reduced rebound after intensive therapy (LYMphoNIGHT, 56 women, Thuasne-funded) — low. Now supported by the independent McNeely 2022 RCT — see below. Borman 2026
  • Garment-first for early BCRL not shown inferior to intensive bandaging (very low). Jeffs 2024

Update 2026-10-09 — papers supplied by Dr Weir

  • Night-time compression (revised 2026-10-09): an independent Canadian RCT (LYNC, 120 women) found night compression added to a day sleeve reduced excess volume by 11–15 percentage points over 12 weeks; self-bandaging worked as well as a US$450 night garment — moderate (sustained benefit low). With LYMphoNIGHT, two trials now agree. McNeely 2022
  • Sleeve at diagnosis of mild BCRL: a class 1 sleeve cut 6-month progression from 57% to 16% (Swedish RCT, 70 women, unblinded measurement) — low; 43% without a sleeve did not progress. Blom 2022

Update 2026-10-09 — open-access batch 3

  • Prophylactic compression after node dissection: delays swelling while worn — arm (Paramanandam 2022, moderate for first year) and leg after groin dissection (Brown 2026: 11% v 45% at 3 months, but 39% v 55% at 24 months, NS — very low). Paramanandam 2022 · Brown 2026
  • Garments first: Dayes 2013 — garments alone nearly as effective as intensive CDT for BCRL (low). Dayes 2013

Update 2026-10-09 — open-access batch 4

  • Non-pneumatic active compression devices (Dayspring, Koya Medical): two crossover trials report large benefits over pneumatic pumps — arm (NILE, 64.6% v 27.7% edema reduction in 28 days) and leg (TEAYS, 370 v 83 mL over 90 days). Both are sponsor-run, unblinded, with self-reported adherence and (TEAYS) a completer analysis — very low. The AVF/AVLS position statement endorsing them relies on these trials only. Rockson 2022 · Barfield 2025 · Jacobowitz 2026
  • Light hosiery in a self-care package after radical hysterectomy reduced 1-year leg lymphoedema (13.6% v 34.5%) — low. Wang 2020
  • Social cost of a sleeve in mild BCRL: more embarrassment and practical burden with a garment (Blom 2023 QoL companion). Blom 2022

Update 2026-10-09 — open-access batch 5

  • Bandage pressure: high pressure not shown better (very low). Duygu-Yildiz 2023
  • Pump adherence: text reminders did not help (Tactile-funded, 29 women). Maingi 2023

Update 2026-10-09 — open-access batch 6

  • Pump dosing: 1 hour daily is enough (Keeley 2023 pilot, very low). Garments during exercise: optional (Wittenkamp 2025). Keeley 2023 · Wittenkamp 2025

How the evidence points

HighMod.LowV. lowNone
Positive02750
Null or negative01630

Sources on this page with a comparison, by the result of their primary outcome and the GRADE certainty of their main finding (Mod. = Moderate, V. low = Very low, None = not graded). Context sources are not counted. How direction is decided.

All 55 sources

More filters
Loading 55 sources…